Hologic (HOLX) Tops Q1 EPS by 95c; Raises Guidance Sharply

Hologic (NASDAQ: HOLX) reported Q1 EPS of $2.17, $0.95 better than the analyst estimate of $1.22. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.13 billion.

GUIDANCE:

Hologic sees FY2022 EPS of $4.90-$5.20, versus the consensus of $3.83. Hologic sees FY2022 revenue of $4.4-4.55 billion, versus the consensus of $4.02 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• UBS Downgrades Buzzi Unicem SpA (BZU:IM) (BZZUY) to Sell
• HP Inc. projects mid-single-digit PC market decline in 2027